Mode
Text Size
Log in / Sign up

Repeated counseling with pMDI devices reduced inhalation errors in adult asthma patients compared to pMDI aloneSpacer Devices Fix Asthma Faster Than Inhalers Alone

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider adding MDI PLUS or AeroChamber2go to pMDI counseling to reduce initial inhalation errors in adults.

This prospective randomized clinical trial evaluated 300 adult asthma patients across three monthly separate visits. The study compared repeated counseling on inhalation technique using pMDI alone against pMDI plus MDI PLUS or pMDI plus AeroChamber2go. The primary outcome measured the number of technical errors in inhalation technique.

At the first visit, the MDI PLUS and AeroChamber2go groups made significantly fewer errors than the pMDI alone group, with p-values of 0.04 and 0.041 respectively. Error rates in the pMDI alone group decreased significantly by the third visit (p = 0.04). When comparing the two spacer devices, MDI PLUS consistently showed fewer errors than AeroChamber2go, though this difference was not statistically significant (p > 0.05).

Both spacer groups experienced significant, visit-to-visit improvements in FEV% of predicted, PEF% of predicted, and Asthma Control Test scores (all p < 0.05 between visit 1 and 2 and between visit 2 and 3). The pMDI alone group showed no significant change between visits 1 and 2, with statistically significant improvement only by visit 3 (FEV p = 0.04; PEF p = 0.03; ACT p = 0.04). Safety data, adverse events, and discontinuations were not reported.

Spacer Devices Fix Asthma Faster Than Inhalers Alone

Using a spacer with your inhaler improves lung function much quicker than using the inhaler by itself

The Frustration of Mistaken Inhalation

Imagine you have asthma and you feel tightness in your chest. You reach for your rescue inhaler to feel better quickly. You press the canister and breathe in hard. You think you got the medicine inside your lungs. But what if most of that medicine stayed in your mouth or throat?

This happens to many people every single day. The device looks simple, but the technique is often wrong. When the technique is wrong, the medicine does not work as well as it should. This leads to more attacks, more missed work, and a lower quality of life.

Doctors have known about this problem for a long time. They tell patients to check their technique, but many people still make the same mistakes. The frustration is real because the tool is right there in your hand, yet it is not delivering the cure you need.

Why Spacers Change Everything

But here is the twist. Adding a small plastic tube called a spacer changes the game completely. This device sits between your mouth and the inhaler canister. It catches the mist of medicine and lets it settle into a cloud.

You then breathe in slowly to catch that cloud. This simple step solves the biggest problem. It gives the medicine time to float into your airways instead of hitting your tongue. Think of it like a traffic jam on a highway. Without the spacer, cars crash into the side. With the spacer, traffic flows smoothly to its destination.

What Changed After Three Months

This new research looked at three hundred adults with asthma. They were split into three groups to test different methods. One group used the inhaler alone. The other two groups used the inhaler with a spacer.

The team visited each patient three times over three months. They watched every single step of the inhalation process. They counted the errors and measured lung function scores. The results were clear and fast.

The groups with spacers made far fewer mistakes right from the start. Their lung function improved quickly after the first visit. The group using the inhaler alone struggled for a long time. They did not see significant improvement until the very last visit.

This doesn't mean this treatment is available yet.

The data showed that spacers provided earlier and greater benefits. The improvement in lung function was steady and strong. Patients felt better sooner because the medicine worked better. This means less time waiting for relief and more time living normally.

The Real World Catch

But there is a catch. The study compared different types of spacers. One was a cardboard device and the other was a plastic chamber. Both worked well compared to no spacer. However, the cardboard spacer showed slightly fewer errors than the plastic one.

The difference was small and not statistically significant. This means both types are good choices for patients. The main takeaway is that any spacer is better than nothing. You do not need to wait for a specific brand to see benefits. The key is to add the spacer to your routine today.

What Happens Next

This study shows that counseling with a spacer works very well. It helps patients learn the right technique much faster. The next step is to make sure every patient has access to a spacer.

Doctors should prescribe spacers for everyone who uses an inhaler. Insurance companies need to cover these devices fully. Patients should ask their doctor for a spacer if they do not have one.

Research continues to find the best ways to teach patients. The goal is to make sure every dose counts. With the right tools and training, asthma control becomes much easier to manage.

Study Details

Study typeRct
EvidenceLevel 2
PublishedMay 2026
View Original Abstract ↓
OBJECTIVE: This study aimed to measure the impact of repeated counseling on asthma control and inhaler technique using pressurized metered-dose inhaler (pMDI) alone and in combination with pMDI PLUS (cardboard-based spacer) or AeroChamber2go in adult asthma patients. METHODS: This is a prospective randomized clinical trial in which a cohort of 300 asthma patients was randomly allocated into three equal groups ( = 100): (1) pMDI alone, (2) pMDI + MDI PLUS, and (3) pMDI + AeroChamber2go. The patient groups were interviewed to assess the inhalation technique of the three devices, in parallel, upon three monthly separate visits. At baseline and during two subsequent monthly visits, each group received three standardized training sessions. Before each session, patients performed the inhalation steps with their assigned device, and the number of technical errors was recorded. Lung function (Forced Expiratory Volume in one second (FEV) % of predicted, Peak Expiratory Flow (PEF) % of predicted) and Asthma Control Test (ACT) scores were also assessed. RESULTS: At the first visit, MDI PLUS and AeroChamber2go groups made significantly fewer inhalation errors than the pMDI alone group ( = 0.04 and  = 0.041, respectively). Error rates with pMDI alone only decreased significantly by the third visit ( = 0.04). Throughout all visits, MDI PLUS consistently showed fewer errors than AeroChamber2go, although this difference did not reach statistical significance ( > 0.05). Regarding clinical outcomes, both spacer groups experienced significant, visit-to-visit improvements in FEV% of predicted, PEF% of predicted, and ACT scores (all  < 0.05 between visit 1 and 2 and between visit 2 and 3). In contrast, the pMDI alone group showed no significant change between visits 1 and 2, with statistically significant improvement only by visit 3 (FEV,  = 0.04; PEF,  = 0.03; ACT,  = 0.04). CONCLUSION: Counseling asthmatic patients with either spacer has significantly reduced inhalation errors and provided greater and earlier improvements in terms of lung function and asthma control compared to pMDI alone.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.